Semaglutide
Supplied by U.S. pharmacies.
Description
Recorded Formulation Facts
- The tracker’s selected pharmacy differs from the pharmacy named in its semaglutide/B6 example.
- Reference labeling identifies semaglutide as a glucagon-like peptide-1 (GLP-1) receptor agonist.[2]
The supplied tracker identifies semaglutide as an injection.[2]
Semaglutide Ingredient Identity
The ingredient class does not resolve the supplier or complete recipe in the supplied records.[2]
Frequently Asked Questions
Is the compounded semaglutide listing approved by the FDA?
Compounded drugs are not FDA-approved.[1]
Does the current listing confirm whether B6 is included in this formulation?
The tracker assigns one pharmacy but gives an example from another pharmacy that names semaglutide with B6.
Information Sources
Compounding Regulatory Status
Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA).[1] The FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.[1]
Physician Consultation and Personalized Care
Opt Health clinical intake includes a diagnostic blood test, medical review of current medications, and a 1:1 consultation with a licensed physician to establish a personalized care plan.[3][4]
Get StartedThis content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.